Sterven met een steunhart

In the Netherlands, approximately 240,000 patients suffer from chronic heart failure, and the incidence is expected to rise in the coming decades. A Left Ventricular Assist Device (LVAD), either temporary or permanent, is increasingly used to treat patients with advanced and end-stage chronic heart failure, with a five-year survival rate exceeding 50%. Healthcare providers in both primary and secondary care will encounter LVAD patients more frequently. Terminal care for LVAD patients requires a specialized approach, with proactive care planning being crucial.

Conflict of interest and financial support: potential conflicts of interest have been reported for this article. ICMJE forms provided by the authors are available online along with the full text of this article.